Dr. Steven Gallinger Co-leads International Study Revealing Novel Molecular Subtypes of Pancreatic Cancer

January 22, 2020

Dr. Faiyaz Notta, (L) scientist with the Princess Margaret Cancer Centre and Ontario Institute for Cancer Research (OICR), and Dr. Steven Gallinger, surgical oncologist at the Princess Margaret, led a team which identified a specific alteration that drives a very aggressive subtype of pancreatic cancer. (Photos: UHN)